1 / 6

Womens Health Diagnostics Market Gaining Demand in Emerging Economies and Future Growth

Global Womens Health Diagnostics Market was valued at $13,133 million in 2016, and is projected to reach $21,501 million at a CAGR of 7.0% from 2017 to 2023. Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases.

newmarketindustry
Télécharger la présentation

Womens Health Diagnostics Market Gaining Demand in Emerging Economies and Future Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Women's Health Diagnostics Market

  2. Smart Polymers Market Overview: Global Women's Health Diagnostics Market was valued at $13,133 million in 2016, and is projected to reach $21,501 million at a CAGR of 7.0% from 2017 to 2023. Women are more prone to certain diseases, mostly related to menstrual disorders, depression, osteoporosis, obesity, and autoimmune diseases. Women's major health issues are related to the reproductive system that includes infertility, polycystic ovarian syndrome, menopause, and cancers such as breast cancer, cervical cancer, and urological disorders. Get Sample Report

  3. Segment Review Diagnostic tests segment accounted for the largest market share in 2016 and is expected to remain so throughout the forecast period. Diagnostic tests involve various tests related to women's health such as pregnancy and ovulation tests, breast cancer tests, ovarian cancer tests, and others. Factors such as high adoption of point-of-care diagnostics, rise in prevalence of women's health-related disorders, and growth in awareness about various tests drives the market for diagnostic tests. In addition, growth in healthcare expenditure, rise in awareness about malignant tumors, and availability of newer and advanced diagnostic systems further boost the womens health diagnostics market growth in near future.

  4. Key Benefits for Stakeholders • The study provides an in-depth analysis of the global womens health diagnostics market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets. • Comprehensive analysis of factors that drive and restrict the womens health diagnostics market growth is provided. • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this womens health diagnostics market on a global & regional scale are provided. • Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the womens health diagnostics market.

  5. The list of key players profiled in this report include Abbott Laboratories, Becton, Dickinson and Company, Carestream Health, F. Hoffmann-La Roche AG, GE Healthcare, Hologic, Inc., Koninklijke Philips N.V., Quest Diagnostics Inc., Cardinal Health, and Siemens AG. Key players in the value chain include MedGyn Products, Inc., Cook Medical Incorporated, Thermo Fisher Scientific, and C. R. Bard, Inc.

More Related